Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 19, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- May 17, 2006: Transfer of 127,695 Ordinary Shares.
- May 18, 2006: Transfer of 40,994 Ordinary Shares.
These transactions were advised to the Company on May 19, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Points
- Verify the total number of shares transferred (168,689) against the company's employee share option plan records.
- Confirm the impact of these transfers on the outstanding share count and potential dilution.
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand vesting conditions.